Sponsored Links
Rockwell Medical's iron deficiency drug succeeds in trial
July 11 |
July 11 (Reuters) - Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving patients' hemoglobin levels.
The study was the first of two planned late-stage trials, and tested the drug, SFP, in adult patients with chronic kidney disease.
- Tweet this
- Link this
- Share this
- Digg this
- Reprints



Follow Reuters